PRIMECAP Management's position in Novartis AG is currently worth $1.27 Billion. That's 0.95% of their equity portfolio (30th largest holding). The first Novartis AG trade was made in Q1 2013. Since then PRIMECAP Management bought shares ten more times and sold shares on 34 occasions. The stake costed the investor $774 Million, netting the investor a gain of 65% so far.
Empire Financial Management Company LLC lessened its … shares during the quarter. Empire Financial Management Company LLC’s holdings …
EIN News Finance, 7 months ago… of two business units: Novartis Oncology and Novartis Pharmaceuticals . See Also Receive News … & Ratings for Novartis Daily - … and analysts'' ratings for...
EIN News Pharmaceuticals, 8 months agoRelated Stocks: NIO , META , AMZN , NVS , TTM ,
GuruFocus, over 1 year agoMadison Funds, managed by Madison Asset Management, LLC, released its “Madison Investors Fund” third quarter 2022 investor letter – a copy of which can be do...
Insider Monkey, over 1 year ago